Menarini announces exclusive distribution agreement for Boditech's AFIAS-10 system

A.Menarini Diagnostics S.r.l. (Menarini) is pleased to announce an exclusive distribution agreement for the AFIAS-10 System and IGRA-TB Assay (among others...

April 20, 2023 | Thursday | News
Collaboration to Improve Early Blood Cancer Detection and Treatment

Juntendo University, Sysmex Corporation, and ThinkCyte K.K. have announced a collaborative research partnership to advance the early detection and treatmen...

April 19, 2023 | Wednesday | News
FDA Approves Cell Therapy for Patients with Blood Cancers to Reduce Risk of Infection Following Stem Cell Transplantation

"Today's approval is an important advance in cell therapy treatment in patients with blood cancers," said Peter Marks, M.D., Ph.D., director of the FDA's C...

April 18, 2023 | Tuesday | News
Scientists from Singapore & Sweden makes progress in restoring vision lost to cellular degeneration

 A preclinical study using stem cells to produce progenitor photoreceptor cells—light-detecting cells found in the eye—and then transplant...

April 17, 2023 | Monday | News
Agena Bioscience and nRichDX Partner for Liquid Biopsy Analyte Extraction and Detection Solutions

Agena Bioscience and nRichDX have advanced their existing technical collaboration to a commercial partnership that co-promotes their products to researcher...

April 17, 2023 | Monday | News
QIAGEN showcases latest technologies to advance cancer research at AACR Annual Meeting 2023

QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced the launch of QIAseq Targeted cfDNA Ultra Panels that will enable researchers studying cancer ...

April 17, 2023 | Monday | News
Daon to Bring Trusted Identity Proofing and Authentication Solutions to Healthcare Industry

Daon, the Digital Identity Trust company, is expanding its identity proofing and authentication solutions to the healthcare industry to enable organization...

April 14, 2023 | Friday | News
Initiation of New Patients on Evobrutinib Paused in the U.S.; Fully Enrolled Phase III Evobrutinib Studies Continue

Merck, a leading science and technology company, today announced the U.S. Food and Drug Administration (FDA) has placed a partial clinical hold on the init...

April 14, 2023 | Friday | News
Aspect Biosystems, Novo Nordisk partner to bioprint tissue therapies for diabetes, obesity.

Partnership will leverage Aspect’s proprietary bioprinting technology and Novo Nordisk’s expertise and technology in stem cell differentiation ...

April 14, 2023 | Friday | News
OM1 Unveils Patented, AI-powered Platform to Accelerate Personalized Medicine

OM1, a leading real-world data, outcomes and technology company with a focus on chronic conditions, today launched PhenOM™, its artificial intelligen...

April 13, 2023 | Thursday | News
From tragedy, a potential pediatric cancer treatment

Cold Spring Harbor Laboratory Professor Adrian Krainer is best known for his groundbreaking research on antisense oligonucleotides (ASOs)—m...

April 13, 2023 | Thursday | News
Fusion Pharmaceuticals Announces IND Clearance for FPI-2068, a Jointly Developed Novel Targeted Alpha Therapy

Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision medic...

April 13, 2023 | Thursday | Regulatory
RxToolKit and NeuroNet Pro Announce Partnership to Improve Clinical Education and Safety for Neurology Practices

This collaboration extends preferred pricing on RxToolKit's software solutions in addition to other exclusive benefits already available to NeuroNet Pro me...

April 12, 2023 | Wednesday | News
ZSFab Announces Second Clinical Use of the ZSFab Cervical Interbody System for ACDF

Dr. Moore performed a 3-level ACDF procedure with theZSFab Cervical Interbody System at The Surgical Hospital of Oklahoma. This was the second case in...

April 11, 2023 | Tuesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close